Jaguar Health Inc
NASDAQ:JAGX

Watchlist Manager
Jaguar Health Inc Logo
Jaguar Health Inc
NASDAQ:JAGX
Watchlist
Price: 1.36 USD 2.26%
Market Cap: 4.8m USD

Relative Value

The Relative Value of one JAGX stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.36 USD, Jaguar Health Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JAGX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
15
Median 3Y
36.6
Median 5Y
266.3
Industry
2.6
Forward
0.3
vs History
vs Industry
Median 3Y
-9.7
Median 5Y
-72.2
Industry
21.7
Forward
-0.1
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-85.1
Industry
16.6
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-65.1
Industry
22.5
vs History
90
vs Industry
12
Median 3Y
9.1
Median 5Y
451.1
Industry
2.3
vs History
95
vs Industry
14
Median 3Y
37.6
Median 5Y
266.6
Industry
2.9
Forward
0.9
vs History
95
vs Industry
17
Median 3Y
47.6
Median 5Y
320.7
Industry
5.5
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-99
Industry
13.1
vs History
vs Industry
Median 3Y
-11.8
Median 5Y
-92.7
Industry
16.6
Forward
-0.5
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-85.2
Industry
15.8
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-81.4
Industry
19.1
vs History
95
vs Industry
29
Median 3Y
9.4
Median 5Y
81.7
Industry
1.9

Multiples Across Competitors

JAGX Competitors Multiples
Jaguar Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Jaguar Health Inc
NASDAQ:JAGX
4.8m USD 0.4 -0.1 -0.4 -0.4
US
Eli Lilly and Co
NYSE:LLY
936.4B USD 16 51.2 34.2 36.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
503.8B USD 5.5 20 16.4 21.3
CH
Roche Holding AG
SIX:ROG
250.8B CHF 4.1 26.6 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
209.7B GBP 4.9 30 108.8 159.3
CH
Novartis AG
SIX:NOVN
201.9B CHF 4.5 17.6 11.2 14.4
US
Merck & Co Inc
NYSE:MRK
243.9B USD 3.8 12.8 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.5 9.5 11
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.7B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
US
Jaguar Health Inc
NASDAQ:JAGX
Average P/E: 23.3
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
51.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.6
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
38%
0.8
CH
Novartis AG
SIX:NOVN
17.6
17%
1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.5
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Jaguar Health Inc
NASDAQ:JAGX
Average EV/EBITDA: 437.6
Negative Multiple: -0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
34.2
33%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.8
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Jaguar Health Inc
NASDAQ:JAGX
Average EV/EBIT: 1 878.5
Negative Multiple: -0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.4
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3